{"id":54457,"date":"2023-03-03T03:03:19","date_gmt":"2023-03-03T02:03:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/"},"modified":"2023-03-03T03:03:19","modified_gmt":"2023-03-03T02:03:19","slug":"dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/","title":{"rendered":"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women"},"content":{"rendered":"
\n

\nIn a historic move, court appoints the most diverse plaintiffs\u2019 team ever to lead a multidistrict litigation<\/i>\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–DiCello Levitt partner Diandra \u201cFu\u201d Debrosse Zimmermann<\/a> today was appointed Plaintiffs\u2019 Co-Lead Counsel in a multidistrict litigation against L\u2019Or\u00e9al and other makers of hair relaxer products marketed primarily to Black and Latin women, alleging that such products are directly linked to uterine and ovarian cancer. The appointments, made by Judge Mary M. Rowland of the U.S. District Court for the Northern District of Illinois, are historic, representing the most diverse plaintiffs\u2019 team ever to lead an MDL.\n<\/p>\n

<\/a><\/p>\n

\nZimmermann is joined as Co-Lead Counsel by Ben Crump of the Ben Crump Law Firm, Fidelma Fitzpatrick of Motley Rice LLC, and Michael A. London of Douglas & London PC. Zimmermann and Crump were the first lawyers to file a mass tort lawsuit last October on behalf of women \u2013 many of whom are Black \u2013 who have contracted or are at greater risk of contracting uterine cancer and other significant health conditions from their use of chemical hair straightening products. Similar lawsuits followed before their transfer and centralization into the MDL, In Re: Hair Relaxer Marketing Sales Practices and Products Liability Litigation<\/i>.\n<\/p>\n

\n\u201cFirst and foremost, today represents an important milestone in our commitment to achieve justice for all women who were assured that these products were safe, and particularly Black women who were primarily targeted as customers,\u201d Zimmermann said. \u201cIt is gratifying that Judge Rowland recognizes the critical importance of appointing a diverse group of lawyers to represent a similarly diverse group of plaintiffs in this matter.\u201d\n<\/p>\n

\nDuring today\u2019s court hearing, Judge Rowland made the unusual decision to appoint the plaintiffs\u2019 leadership team directly from the bench, noting the high quality and deep well of experience demonstrated by the leadership applicants\u2014all of which was demonstrated in the leadership team\u2019s application, which emphasized their diversity, similar professional experience, willingness and resources to commit to a time-consuming project, and the ability to work cooperatively with others.\n<\/p>\n

\nZimmermann and Crump filed the original complaint in October 2022, around the same time that the National Cancer Institute published a study<\/a> conducted by the National Institute of Health that found that frequent users of chemical hair straightening products were more than twice as likely to develop uterine cancer as those who didn\u2019t use those products. That finding was particularly alarming for Black women, who report using hair straightening products more than other populations. Chemical hair straighteners typically contain products associated with higher cancer risk, including formaldehyde, metals, phthalates, and parabens, which may be more easily absorbed by the body through scalp burns and abrasions often caused by chemical straighteners.\n<\/p>\n

\nZimmermann and Crump founded the organization, Shades of Mass, in 2022 to combat the lack of diverse attorney leadership in MDLs. Co-Chair of DiCello Levitt\u2019s Mass Tort practice group, Zimmermann is widely recognized for her relentless client advocacy, representing individuals and public entities injured by wrongful conduct, whether from defective medical devices or drugs, environmental contamination, corporate misconduct, and civil rights abuses.\n<\/p>\n

\nAbout DiCello Levitt<\/b>\n<\/p>\n

\nAt DiCello Levitt, we\u2019re dedicated to achieving justice for our clients through mass tort, class action, business-to-business, public client, whistleblower, and personal injury litigation. Our lawyers are highly respected for their ability to litigate and win cases\u2014whether by trial, settlement, or otherwise\u2014for people who have suffered harm, global corporations that have sustained significant economic losses, and public clients seeking to protect their citizens\u2019 rights and interests. Every day, we put our reputations\u2014and our capital\u2014on the line for our clients. dicellolevitt.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLaura Gingiss
\n
773-469-1059
\n
lgingiss@baretzbrunelle.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

In a historic move, court appoints the most diverse plaintiffs\u2019 team ever to lead a multidistrict litigation CHICAGO–(BUSINESS WIRE)–DiCello Levitt partner Diandra \u201cFu\u201d Debrosse Zimmermann today was appointed Plaintiffs\u2019 Co-Lead Counsel in a multidistrict litigation against L\u2019Or\u00e9al and other makers of hair relaxer products marketed primarily to Black and Latin women, alleging that such products … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54457","6":"format-standard","7":"category-industry"},"yoast_head":"\nDiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"In a historic move, court appoints the most diverse plaintiffs\u2019 team ever to lead a multidistrict litigation CHICAGO–(BUSINESS WIRE)–DiCello Levitt partner Diandra \u201cFu\u201d Debrosse Zimmermann today was appointed Plaintiffs\u2019 Co-Lead Counsel in a multidistrict litigation against L\u2019Or\u00e9al and other makers of hair relaxer products marketed primarily to Black and Latin women, alleging that such products ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-03T02:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230302005937\/en\/1729193\/21\/DL_Logo_K.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women\",\"datePublished\":\"2023-03-03T02:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/\"},\"wordCount\":629,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005937\\\/en\\\/1729193\\\/21\\\/DL_Logo_K.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/\",\"name\":\"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005937\\\/en\\\/1729193\\\/21\\\/DL_Logo_K.jpg\",\"datePublished\":\"2023-03-03T02:03:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005937\\\/en\\\/1729193\\\/21\\\/DL_Logo_K.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005937\\\/en\\\/1729193\\\/21\\\/DL_Logo_K.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/","og_locale":"en_US","og_type":"article","og_title":"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women - Pharma Trend","og_description":"In a historic move, court appoints the most diverse plaintiffs\u2019 team ever to lead a multidistrict litigation CHICAGO–(BUSINESS WIRE)–DiCello Levitt partner Diandra \u201cFu\u201d Debrosse Zimmermann today was appointed Plaintiffs\u2019 Co-Lead Counsel in a multidistrict litigation against L\u2019Or\u00e9al and other makers of hair relaxer products marketed primarily to Black and Latin women, alleging that such products ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-03T02:03:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230302005937\/en\/1729193\/21\/DL_Logo_K.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women","datePublished":"2023-03-03T02:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/"},"wordCount":629,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230302005937\/en\/1729193\/21\/DL_Logo_K.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/","url":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/","name":"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230302005937\/en\/1729193\/21\/DL_Logo_K.jpg","datePublished":"2023-03-03T02:03:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230302005937\/en\/1729193\/21\/DL_Logo_K.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230302005937\/en\/1729193\/21\/DL_Logo_K.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dicello-levitts-fu-zimmermann-appointed-to-lead-litigation-against-loreal-and-others-over-cancer-causing-hair-relaxer-products-marketed-to-minority-women\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"DiCello Levitt\u2019s \u201cFu\u201d Zimmermann Appointed to Lead Litigation Against L\u2019Or\u00e9al and Others Over Cancer-Causing Hair Relaxer Products Marketed to Minority Women"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54457"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54457\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}